Вcl2 биологические и клинические аспекты. Локализация и возможные функции, страница 13

24. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Langwecker R., Kieff E., Rickinson A. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.// Cell.-1991.- Vol.65.-P.1107-1115.

25. McDonnel T.J., Deane N., Platt F.M. Nunez G., Jaeger U., McKearn J.P., Korsmeyer S.J. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.// Cell.-1989.-Vol.57.-P.79-88.

26. Boise L.H., Gonzelez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death.// Cell.-1993.-Vol.-74.-P.597-608.

27. Liu J., Hernandez A.M., Shibata D., Cortopassi G.A. BCL-2 translocation frequency rises with age in humans.// Proc. Natl. Acad. Sci. USA.-1994.-Vol.91.-P.8910-8914.

28. Reed J.C., Cuddy M., Haldar S., Croce C., Nowell P., Macober D., Bradley K. BCL-2 mediated tumorigenecity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL-2 antisense.// Proc. Natl. Acad. Sci. USA.-1990.- Vol.87.- P.3660-3664.

29. Rao L., Debbas M.,  Sabbatini P., Hockenberg D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19 kDa and Bcl-2 proteins.// Proc. Natl. Acad. Sci. USA.-1992.-Vol.89.-P.7742-7746.

30. Doelken G., Illerhaus G., Hirt C., Merstellmann R. BCL-2 / J_H  rearrangements of circulating B cells in healthy blood donors and patients with nonmalignant diseases.// J. Clin. Oncol.-Vol.14.-P.1333-1344.

31. Korsmeyer S.J. et al. Reactive oxygen species and the regulation of cell death by the bcl-2 gene family.// Biochim. Biophys. Acta.-1995.-Vol.1271.-P.63-66.

32. Hermine O. et al. Prognostic significance of Bcl-2 protein expression in aggressive non-Hodgkin’s lymphoma.// Blood.-1996.-Vol.87.-P.265-272.

33. Corradini P. et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin’s lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.// Blood.-1997.-Vol.89.-P.724-731.

34. Tilly H. et al. Prognostic value of chromosomal abnormalities in follicular lymphoma.// Blood.-1994.-Vol.84-.P.1043-1049.

35. Hill M.E. et al. Prognostic significance of Bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large-cell non-Hodgkin’s lymphoma: a British National Lymphoma Investigation Study.// Blood.-1996.-Vol.88.-P.1046-1051.

36. Osorio L.M. et al. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.// Blood.-1997.-Vol.89.-P.2833-2841.

37. Reed J.C. Bcl-2 and the regulation of the programmed cell death.// J. Cell. Biol.-1994.-Vol.124.-P.11-15.

38. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: regulators of cell death.// Blood.-1992.-Vol.80.-P.879-883.

39. Aguilar-Santelisez M., Rottenberg M., Lewin N. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro cell survival and clinical progression.// Int. J. Cancer.-1996.-Vol.69.-P.114-117.

40. Findley H.W., Gu L., Yeager A.M., Zhou M. Expression and regulation of Bcl-2, Bcl-Xl and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.// Blood.-1997.-Vol.89.-P.2986-2993.

41. Campos L., Rounalt J.P., Salido O., Oriol P., Roubi N., Vasselon C., Archimband E., Magand J.P., Guyotat D. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.// Blood.-1993.-Vol.81.-P.3091-3095.

42. Porwit-MacDonald A., Ivory K., Wilkinson S., Wheatley K., Wong L., Janossy G. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.// Leukemia.-1991.-Vol.9.-P.1191-1196.

43. Gregory C.D. Apoptosis: a role in neoplasia?// In “Cell proliferation in cancer: regulatory mechanisms of neoplastic cell growth.” - Ed. by Pustall L. - Oxford Medical Publication, 1996.-P.343-367.